Evidence map›Paper›PMID 41316445›Full record

ReviewTropical medicine and health2025

Leveraging a people-centred approach to combat antimicrobial resistance in Africa.

Yusuff Adebayo Adebisi, Wuraola Akande-Sholabi, Nafisat Dasola Jimoh, Hajar Lali, Kehinde Asake Adebowale, Amal Ouachhou, Kenneth Chukwuebuka Egwu, Loureen Valyne Nachibwede, Deborah Oluwaseun Shomuyiwa, Ahishakiye Gilbert and 3 more

Abstract readReview
In one paragraph

Review in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yusuff Adebayo AdebisiGlobal Health Focus, Abuja, Nigeria. adebisiyusuff23@yahoo.com.
Wuraola Akande-SholabiDepartment of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
Nafisat Dasola JimohGlobal Health Focus, Abuja, Nigeria.
Hajar LaliFaculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Kehinde Asake AdebowaleDepartment for Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Amal OuachhouFaculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Kenneth Chukwuebuka EgwuDepartment of Pharmacy, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Loureen Valyne NachibwedeSchool of Public Health, Jomo Kenyatta University of Agriculture and Technology-JKUAT, Juja, Kenya.
Deborah Oluwaseun ShomuyiwaCollege of Public Health, University of Georgia, Athens, GA, USA.
Ahishakiye GilbertCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
David OlpengsAmref Health Africa, Nairobi, Kenya.
Noah SesayMinistry of Health of Sierra Leone, Ola During Children's Hospital, Freetown, Sierra Leone.
Iyiola Olatunji OladunjoyeDepartment of Microbiology, Faculty of Life Sciences, University of Ilorin, Ilorin, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses a severe and growing threat to public health in Africa, disproportionately affecting marginalised and vulnerable populations across communities and health systems. Current responses often prioritise technical measures, such as stewardship programmes and surveillance systems, with insufficient attention to the socioeconomic and cultural realities that drive resistance. AMR cannot be addressed in isolation, as its emergence and spread are closely linked to poverty, inadequate education, gender inequality, poor governance, limited access to healthcare, clean water, sanitation, and diagnostics, as well as weak supply chains for essential medicines. This commentary advocates for a people-centred approach to AMR that addresses the social determinants of health and fosters inclusive, community-driven solutions. Strengthening primary healthcare systems and improving access to affordable, quality-assured antimicrobials and diagnostics must be prioritised to empower both healthcare providers and patients. Local stakeholders are essential for raising awareness, promoting behaviour change, and ensuring cultural relevance through meaningful community engagement. Marginalised populations, including those in underserved regions or disproportionately exposed to infection due to displacement, disability, or comorbidities, should be central to the co-creation of AMR strategies. Embedding AMR initiatives within universal health coverage reforms, expanding preventive measures, such as vaccination, and tackling systemic challenges are also crucial for reducing antibiotic dependence and building equitable health systems. A coordinated, multisectoral response that connects human, animal, and environmental health, grounded in equity, community ownership, and interdisciplinary collaboration, is essential for sustainable AMR control efforts that leave no one behind.

Indexed as

AfricaAntimicrobial resistanceAntimicrobialsPeople-centred approachPublic health

Identifiers

PMID41316445
PMCPMC12667054

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.